03:09 AM EDT, 04/28/2026 (MT Newswires) -- Jason P Rhodes, Director, on April 23, 2026, sold 384,549 shares in Dyne Therapeutics (DYN) for $7,101,120. Following the Form 4 filing with the SEC, Rhodes has control over a total of 1,206,026 common shares of the company, with 1,206,026 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1818794/000157701426000004/xslF345X05/form4-04272026_100429.xml

Ämnen i artikeln

Dyne Therapeutics

Senast

18,16

1 dag %

0,67%

1 dag

1 mån

1 år

Marknadsöversikt

1 DAG %

Senast

1 mån